Axon guidance proteins in neurological disorders

The Lancet Neurology

Volumn 14, Issue 5, 2015, Pages 532-546

  Van Battum, Eljo Y ^a   Brignani, Sara ^a   Pasterkamp, R Jeroen ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE PROTEIN; EPHRIN; NERVE GROWTH FACTOR; SEMAPHORIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; AUTISM; CONGENITAL MIRROR MOVEMENT; DEGENERATIVE DISEASE; DISEASE PREDISPOSITION; DYSLEXIA; EPILEPSY; GAZE PARALYSIS; GENE MUTATION; HIRSCHSPRUNG DISEASE; HUMAN; KALLMANN SYNDROME; NERVE CELL PLASTICITY; NERVE FIBER; NEUROLOGIC DISEASE; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SCOLIOSIS; SYNAPSE; ANIMAL; METABOLISM; NERVE CELL NETWORK; PATHOLOGY;

ANIMALS; AXONS; EPHRINS; HUMANS; NERVE GROWTH FACTOR; NERVE NET; NERVE TISSUE PROTEINS; NERVOUS SYSTEM DISEASES; SEMAPHORINS;

EID: 84928089132     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(14)70257-1     Document Type: Review

References (113)

1. Kolodkin AL, Tessier-Lavigne M Mechanisms and molecules of neuronal wiring: a primer. Cold Spring Harb Perspect Biol 2011, 3. pii: a001727.
2. Pasterkamp RJ, Kolodkin AL SnapShot: Axon Guidance. Cell 2013, 153:494. 494e1-2.
3. Izzi L, Charron F Midline axon guidance and human genetic disorders. Clin Genet 2011, 80:226-234.
4. Nugent AA, Kolpak AL, Engle EC Human disorders of axon guidance. Curr Opin Neurobiol 2012, 22:837-843.
5. Geschwind DH, Levitt P Autism spectrum disorders: developmental disconnection syndromes. Curr Opin Neurobiol 2007, 17:103-111.
6. Amaral DG, Schumann CM, Nordahl CW Neuroanatomy of autism. Trends Neurosci 2008, 31:137-145.
7. McFadden K, Minshew NJ Evidence for dysregulation of axonal growth and guidance in the etiology of ASD. Front Hum Neurosci 2013, 7:671.
8. Lin L, Lesnick TG, Maraganore DM, Isacson O Axon guidance and synaptic maintenance: preclinical markers for neurodegenerative disease and therapeutics. Trends Neurosci 2009, 32:142-149.
9. Schmidt ERE, Pasterkamp RJ, van den Berg LH Axon guidance proteins: novel therapeutic targets for ALS?. Prog Neurobiol 2009, 88:286-301.
10. Kubo T, Tokita S, Yamashita T Repulsive guidance molecule-A and demyelination: implications for multiple sclerosis. J Neuroimmune Pharmacol 2012, 7:524-528.
11. Kumanogoh A, Kikutani H Immunological functions of the neuropilins and plexins as receptors for semaphorins. Nat Rev Immunol 2013, 13:802-814.
12. Pasterkamp RJ Getting neural circuits into shape with semaphorins. Nat Rev Neurosci 2012, 13:605-618.
13. Lai Wing Sun K, Correia JP, Kennedy TE Netrins: versatile extracellular cues with diverse functions. Development 2011, 138:2153-2169.
14. Ypsilanti AR, Zagar Y, Chédotal A Moving away from the midline: new developments for Slit and Robo. Development 2010, 137:1939-1952.
15. Severyn CJ, Shinde U, Rotwein P Molecular biology, genetics and biochemistry of the repulsive guidance molecule family. Biochem J 2009, 422:393-403.
16. Klein R Eph/ephrin signalling during development. Development 2012, 139:4105-4109.
17. Avilés EC, Wilson NH, Stoeckli ET Sonic hedgehog and Wnt: antagonists in morphogenesis but collaborators in axon guidance. Front Cell Neurosci 2013, 7:86.
18. Charron F, Tessier-Lavigne M The Hedgehog, TGF-beta/BMP and Wnt families of morphogens in axon guidance. Adv Exp Med Biol 2007, 621:116-133.
19. Hollis ER, Zou Y Expression of the Wnt signaling system in central nervous system axon guidance and regeneration. Front Mol Neurosci 2012, 5:5.
20. Jongbloets BC, Pasterkamp RJ Semaphorin signalling during development. Development 2014, 141:3292-3297.
21. Chédotal A Further tales of the midline. Curr Opin Neurobiol 2011, 21:68-75.
22. Nawabi H, Castellani V Axonal commissures in the central nervous system: how to cross the midline?. Cell Mol Life Sci 2011, 68:2539-2553.
23. Edwards TJ, Sherr EH, Barkovich AJ, Richards LJ Clinical, genetic and imaging findings identify new causes for corpus callosum development syndromes. Brain 2014, 137:1579-1613.
24. Engle EC Human genetic disorders of axon guidance. Cold Spring Harb Perspect Biol 2010, 2:a001784.
25. Srour M, Rivière J-B, Pham JMT, et al. Mutations in DCC cause congenital mirror movements. Science 2010, 328:592.
26. Depienne C, Cincotta M, Billot S, et al. A novel DCC mutation and genetic heterogeneity in congenital mirror movements. Neurology 2011, 76:260-264.
27. Jen JC, Chan W-M, Bosley TM, et al. Mutations in a human ROBO gene disrupt hindbrain axon pathway crossing and morphogenesis. Science 2004, 304:1509-1513.
28. Chan W-M, Traboulsi EI, Arthur B, Friedman N, Andrews C, Engle EC Horizontal gaze palsy with progressive scoliosis can result from compound heterozygous mutations in ROBO3. J Med Genet 2006, 43:e11.
29. Abu-Amero KK, al Dhalaan H, al Zayed Z, Hellani A, Bosley TM Five new consanguineous families with horizontal gaze palsy and progressive scoliosis and novel ROBO3 mutations. J Neurol Sci 2009, 276:22-26.
30. Amouri R, Nehdi H, Bouhlal Y, Kefi M, Larnaout A, Hentati F Allelic ROBO3 heterogeneity in Tunisian patients with horizontal gaze palsy with progressive scoliosis. J Mol Neurosci 2009, 39:337-341.
31. Hannula-Jouppi K, Kaminen-Ahola N, Taipale M, et al. The axon guidance receptor gene ROBO1 is a candidate gene for developmental dyslexia. PLoS Genet 2005, 1:e50.
32. Lamminmäki S, Massinen S, Nopola-Hemmi J, Kere J, Hari R Human ROBO1 regulates interaural interaction in auditory pathways. J Neurosci 2012, 32:966-971.
33. Bates TC, Luciano M, Medland SE, Montgomery GW, Wright MJ, Martin NG Genetic variance in a component of the language acquisition device: ROBO1 polymorphisms associated with phonological buffer deficits. Behav Genet 2011, 41:50-57.
34. Mascheretti S, Riva V, Giorda R, et al. KIAA0319 and ROBO1: evidence on association with reading and pleiotropic effects on language and mathematics abilities in developmental dyslexia. J Hum Genet 2014, 59:189-197.
35. Tran C, Wigg KG, Zhang K, et al. Association of the ROBO1 gene with reading disabilities in a family-based analysis. Genes Brain Behav 2014, 13:430-438.
36. Francks C, Fisher SE, Olson RK, et al. Fine mapping of the chromosome 2p12-16 dyslexia susceptibility locus: quantitative association analysis and positional candidate genes SEMA4F and OTX1. Psychiatr Genet 2002, 12:35-41.
37. Hanchate NK, Giacobini P, Lhuillier P, et al. SEMA3A, a gene involved in axonal pathfinding, is mutated in patients with Kallmann syndrome. PLoS Genet 2012, 8:e1002896.
38. Young J, Metay C, Bouligand J, et al. SEMA3A deletion in a family with Kallmann syndrome validates the role of semaphorin 3A in human puberty and olfactory system development. Hum Reprod 2012, 27:1460-1465.
39. Känsäkoski J, Fagerholm R, Laitinen E-M, et al. Mutation screening of SEMA3A and SEMA7A in patients with congenital hypogonadotropic hypogonadism. Pediatr Res 2014, 75:641-644. 10.1038/pr.2014.23.
40. Wang L-L, Zhang Y, Fan Y, et al. SEMA3A rs7804122 polymorphism is associated with Hirschsprung disease in the Northeastern region of China. Birth Defects Res A Clin Mol Teratol 2012, 94:91-95.
41. Luzón-Toro B, Fernández RM, Torroglosa A, et al. Mutational spectrum of semaphorin 3A and semaphorin 3D genes in Spanish Hirschsprung patients. PLoS One 2013, 8:e54800.
42. Wu S, Yue W, Jia M, et al. Association of the neuropilin-2 (NRP2) gene polymorphisms with autism in Chinese Han population. Am J Med Genet B Neuropsychiatr Genet 2007, 144B:492-495.
43. Anitha A, Nakamura K, Yamada K, et al. Genetic analyses of roundabout (ROBO) axon guidance receptors in autism. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:1019-1027.
44. Hussman JP, Chung R-H, Griswold AJ, et al. A noise-reduction GWAS analysis implicates altered regulation of neurite outgrowth and guidance in autism. Mol Autism 2011, 2:1.
45. Suda S, Iwata K, Shimmura C, et al. Decreased expression of axon-guidance receptors in the anterior cingulate cortex in autism. Mol Autism 2011, 2:14.
46. Melin M, Carlsson B, Anckarsater H, et al. Constitutional downregulation of SEMA5A expression in autism. Neuropsychobiology 2006, 54:64-69.
47. Sbacchi S, Acquadro F, Calò I, Calì F, Romano V Functional annotation of genes overlapping copy number variants in autistic patients: focus on axon pathfinding. Curr Genomics 2010, 11:136-145.
48. Holtmaat AJGD, Gorter JA, De Wit J, et al. Transient downregulation of Sema3A mRNA in a rat model for temporal lobe epilepsy. A novel molecular event potentially contributing to mossy fiber sprouting. Exp Neurol 2003, 182:142-150.
49. Xu B, Li S, Brown A, Gerlai R, Fahnestock M, Racine RJ EphA/ephrin-A interactions regulate epileptogenesis and activity-dependent axonal sprouting in adult rats. Mol Cell Neurosci 2003, 24:984-999.
50. Xia Y, Luo C, Dai S, Yao D Increased EphA/ephrinA expression in hippocampus of pilocarpine treated mouse. Epilepsy Res 2013, 105:20-29.
51. Barnes G, Puranam RS, Luo Y, McNamara JO Temporal specific patterns of semaphorin gene expression in rat brain after kainic acid-induced status epilepticus. Hippocampus 2003, 13:1-20.
52. Fang M, Liu G-W, Pan Y-M, et al. Abnormal expression and spatiotemporal change of Slit2 in neurons and astrocytes in temporal lobe epileptic foci: a study of epileptic patients and experimental animals. Brain Res 2010, 1324:14-23.
53. Uyan Ö, Ömür Ö, Ağim ZS, et al. Genome-wide copy number variation in sporadic amyotrophic lateral sclerosis in the Turkish population: deletion of EPHA3 is a possible protective factor. PLoS One 2013, 8:e72381.
54. Van Hoecke A, Schoonaert L, Lemmens R, et al. EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans. Nat Med 2012, 18:1418-1422.
55. De Winter F, Vo T, Stam FJ, et al. The expression of the chemorepellent Semaphorin 3A is selectively induced in terminal Schwann cells of a subset of neuromuscular synapses that display limited anatomical plasticity and enhanced vulnerability in motor neuron disease. Mol Cell Neurosci 2006, 32:102-117.
56. Xie T, Deng L, Mei P, et al. Genome-wide association study combining pathway analysis for typical sporadic amyotrophic lateral sclerosis in Chinese Han populations. Neurobiol Aging 2014, 35:e9-e23.
57. Kim J-M, Park SK, Yang JJ, et al. SNPs in axon guidance pathway genes and susceptibility for Parkinson's disease in the Korean population. J Hum Genet 2011, 56:125-129.
58. Maraganore DM, de Andrade M, Lesnick TG, et al. High-resolution whole-genome association study of Parkinson disease. Am J Hum Genet 2005, 77:685-693.
59. Yu X, Wang F, Zhang JP Meta analysis of the association of rs7702187 SNP in SEMA5A gene with risk of Parkinson's disease. Eur Rev Med Pharmacol Sci 2014, 18:900-904.
60. Lesnick TG, Papapetropoulos S, Mash DC, et al. A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. PLoS Genet 2007, 3:e98.
61. Srinivasan BS, Doostzadeh J, Absalan F, et al. Whole genome survey of coding SNPs reveals a reproducible pathway determinant of Parkinson disease. Hum Mutat 2009, 30:228-238.
62. Bossers K, Meerhoff G, Balesar R, et al. Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death. Brain Pathol 2009, 19:91-107.
63. Simón AM, de Maturana RL, Ricobaraza A, et al. Early changes in hippocampal Eph receptors precede the onset of memory decline in mouse models of Alzheimer's disease. J Alzheimers Dis 2009, 17:773-786.
64. Vargas LM, Leal N, Estrada LD, et al. EphA4 activation of c-Abl mediates synaptic loss and LTP blockade caused by amyloid-β oligomers. PLoS One 2014, 9:e92309.
65. Lourenço FC, Galvan V, Fombonne J, et al. Netrin-1 interacts with amyloid precursor protein and regulates amyloid-beta production. Cell Death Differ 2009, 16:655-663.
66. Cissé M, Halabisky B, Harris J, et al. Reversing EphB2 depletion rescues cognitive functions in Alzheimer model. Nature 2011, 469:47-52.
67. Good PF, Alapat D, Hsu A, et al. A role for semaphorin 3A signaling in the degeneration of hippocampal neurons during Alzheimer's disease. J Neurochem 2004, 91:716-736.
68. Petratos S, Li Q-X, George AJ, et al. The beta-amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism. Brain 2008, 131:90-108.
69. Antonell A, Lladó A, Altirriba J, et al. A preliminary study of the whole-genome expression profile of sporadic and monogenic early-onset Alzheimer's disease. Neurobiol Aging 2013, 34:1772-1778.
70. Hollingworth P, Harold D, Sims R, et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 2011, 43:429-435. for the Alzheimer's Disease Neuroimaging Initiative, the CHARGE consortiumthe CHARGE consortium, the EADI1 consortiumthe EADI1 consortium.
71. Naj AC, Jun G, Beecham GW, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet 2011, 43:436-441.
72. Fazeli A, Dickinson SL, Hermiston ML, et al. Phenotype of mice lacking functional Deleted in colorectal cancer (Dcc) gene. Nature 1997, 386:796-804.
73. Djarmati-Westenberger A, Brüggemann N, Espay AJ, Bhatia KP, Klein C A novel DCC mutation and genetic heterogeneity in congenital mirror movements. Neurology 2011, 77:1580.
74. Renier N, Schonewille M, Giraudet F, et al. Genetic dissection of the function of hindbrain axonal commissures. PLoS Biol 2010, 8:e1000325.
75. Scerri TS, Schulte-Körne G Genetics of developmental dyslexia. Eur Child Adolesc Psychiatry 2010, 19:179-197.
76. Andrews W, Liapi A, Plachez C, et al. Robo1 regulates the development of major axon tracts and interneuron migration in the forebrain. Development 2006, 133:2243-2252.
77. Venkatesh SK, Siddaiah A, Padakannaya P, Ramachandra NB Lack of association between genetic polymorphisms in ROBO1, MRPL19/C2ORF3 and THEM2 with developmental dyslexia. Gene 2013, 529:215-219.
78. Marín O, Valiente M, Ge X, Tsai LH Guiding neuronal cell migrations. Cold Spring Harb Perspect Biol 2010, 2:a001834.
79. Dodé C, Hardelin J-P Clinical genetics of Kallmann syndrome. Ann Endocrinol 2010, 71:149-157.
80. Cariboni A, Davidson K, Rakic S, Maggi R, Parnavelas JG, Ruhrberg C Defective gonadotropin-releasing hormone neuron migration in mice lacking SEMA3A signalling through NRP1 and NRP2: implications for the aetiology of hypogonadotropic hypogonadism. Hum Mol Genet 2011, 20:336-344.
81. Giacobini P, Prevot V Semaphorins in the development, homeostasis and disease of hormone systems. Semin Cell Dev Biol 2013, 24:190-198.
82. Messina A, Ferraris N, Wray S, et al. Dysregulation of Semaphorin7A/β1-integrin signaling leads to defective GnRH-1 cell migration, abnormal gonadal development and altered fertility. Hum Mol Genet 2011, 20:4759-4774.
83. Giacobini P, Messina A, Morello F, et al. Semaphorin 4D regulates gonadotropin hormone-releasing hormone-1 neuronal migration through PlexinB1-Met complex. J Cell Biol 2008, 183:555-566.
84. Cariboni A, Andrews WD, Memi F, et al. Slit2 and Robo3 modulate the migration of GnRH-secreting neurons. Development 2012, 139:3326-3331.
85. Romeo G, Ronchetto P, Luo Y, et al. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature 1994, 367:377-378.
86. Best KE, Addor M-C, Arriola L, et al. Hirschsprung's disease prevalence in Europe: A register based study. Birth Defects Res Part A Clin Mol Teratol 2014, 100:695-702.
87. Schuchardt A, D'Agati V, Larsson-Blomberg L, Costantini F, Pachnis V Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 1994, 367:380-383.
88. Wang L-L, Fan Y, Zhou F-H, et al. Semaphorin 3A expression in the colon of Hirschsprung disease. Birth Defects Res A Clin Mol Teratol 2011, 91:842-847.
89. Anderson RB, Bergner AJ, Taniguchi M, et al. Effects of different regions of the developing gut on the migration of enteric neural crest-derived cells: a role for Sema3A, but not Sema3F. Dev Biol 2007, 305:287-299.
90. Huguet G, Ey E, Bourgeron T The genetic landscapes of autism spectrum disorders. Annu Rev Genomics Hum Genet 2013, 14:191-213.
91. Koyama R1, Ikegaya Y Mossy fiber sprouting as a potential therapeutic target for epilepsy. Curr Neurovasc Res 2004, 1:3-10.
92. Babb TL, Pretorius JK, Mello LE, Mathern GW, Levesque MF Synaptic reorganizations in epileptic human and rat kainate hippocampus may contribute to feedback and feedforward excitation. Epilepsy Res Suppl 1992, 9:193-202.
93. Houser CR Granule cell dispersion in the dentate gyrus of humans with temporal lobe epilepsy. Brain Res 1990, 535:195-204.
94. Murray LM, Talbot K, Gillingwater TH Review: neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy. Neuropathol Appl Neurobiol 2010, 36:133-156.
95. Saxena S, Caroni P Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration. Neuron 2011, 71:35-48.
96. Lai KO, Ip NY Synapse development and plasticity: roles of ephrin/Eph receptor signaling. Curr Opin Neurobiol 2009, 19:275-283.
97. Pasterkamp RJ, Giger RJ Semaphorin function in neural plasticity and disease. Curr Opin Neurobiol 2009, 19:263-274.
98. Robberecht W, Philips T The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci 2013, 14:248-264.
99. Dupuis L, Gonzalez de Aguilar J-L, di Scala F, et al. Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis. Neurobiol Dis 2002, 10:358-365.
100. Bros-Facer V, Krull D, Taylor A, et al. Treatment with an antibody directed against Nogo-A delays disease progression in the SOD1G93A mouse model of Amyotrophic lateral sclerosis. Hum Mol Genet 2014, 23:4187-4200.
101. Jiang Y-M, Yamamoto M, Kobayashi Y, et al. Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Ann Neurol 2005, 57:236-251.
102. Lesnick TG, Sorenson EJ, Ahlskog JE, et al. Beyond Parkinson disease: amyotrophic lateral sclerosis and the axon guidance pathway. PLoS One 2008, 3:e1449.
103. Li J, Li T, Zhang X, Tang Y, Yang J, Le W Human superoxide dismutase 1 overexpression in motor neurons of Caenorhabditis elegans causes axon guidance defect and neurodegeneration. Neurobiol Aging 2014, 35:837-846.
104. Van den Heuvel DMA, Pasterkamp RJ Getting connected in the dopamine system. Prog Neurobiol 2008, 85:75-93.
105. Bjorklund A, Kordower JH Cell therapy for Parkinson's disease: what next?. Mov Disord 2013, 28:110-115.
106. Soutar MPM, Thornhill P, Cole AR, Sutherland C Increased CRMP2 phosphorylation is observed in Alzheimer's disease; does this tell us anything about disease development?. Curr Alzheimer Res 2009, 6:269-278.
107. Bai G, Chivatakarn O, Bonanomi D, et al. Presenilin-dependent receptor processing is required for axon guidance. Cell 2011, 144:106-118.
108. Marchetto MCN, Carromeu C, Acab A, et al. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 2010, 143:527-539.
109. Prilutsky D, Palmer NP, Smedemark-Margulies N, Schlaeger TM, Margulies DM, Kohane IS iPSC-derived neurons as a higher-throughput readout for autism: promises and pitfalls. Trends Mol Med 2014, 20:91-104.
110. Zukin RS, Richter JD, Bagni C Signals, synapses, and synthesis: how new proteins control plasticity. Front Neural Circuits 2009, 3:14.
111. Jung H, Yoon BC, Holt CE Axonal mRNA localization and local protein synthesis in nervous system assembly, maintenance and repair. Nat Rev Neurosci 2012, 13:308-324.
112. Ferrario JE, Baskaran P, Clark C, et al. Axon guidance in the developing ocular motor system and Duane retraction syndrome depends on Semaphorin signaling via alpha2-chimaerin. Proc Natl Acad Sci USA 2012, 109:14669-14674.
113. Gorter JA, Iyer A, White I, et al. Hippocampal subregion-specific microRNA expression during epileptogenesis in experimental temporal lobe epilepsy. Neurobiol Dis 2014, 62:508-520.